Fig. 1. TR treatment with or without DEXA were non-toxic to HTMC viability.
Percentage viability of HTMC following treatment for (A) three days and (B) seven days. Bars represent mean ± SD (n = 3). p > 0.05, ANOVA with Tukey’s post-hoc. TR, resveratrol; DEXA, dexamethasone; HTMC, human trabecular meshwork cell; DMEM, Dulbecco’s modified Eagle medium; DMSO, dimethyl sulfoxide.
© Korean J Physiol Pharmacol
